Suheung Co., Ltd. (KRX:008490)
13,530
+40 (0.30%)
At close: Apr 16, 2025, 3:30 PM KST
Suheung Revenue
In the year 2024, Suheung had annual revenue of 653.26B KRW with 9.87% growth. Suheung had revenue of 148.57B in the quarter ending December 31, 2024, with 11.53% growth.
Revenue
653.26B
Revenue Growth
+9.87%
P/S Ratio
0.23
Revenue / Employee
887.59M
Employees
736
Market Cap
147.77B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 653.26B | 58.70B | 9.87% |
Dec 31, 2023 | 594.57B | -40.40B | -6.36% |
Dec 31, 2022 | 634.97B | 38.23B | 6.41% |
Dec 31, 2021 | 596.73B | 43.72B | 7.91% |
Dec 31, 2020 | 553.01B | 92.28B | 20.03% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,547.32B |
Celltrion | 3,557.30B |
ALTEOGEN | 102.85B |
Yuhan | 2,067.79B |
SK Biopharmaceuticals | 547.60B |
HLB Co., Ltd. | 68.13B |
LigaChem Biosciences | 125.90B |
PharmaResearch | 350.12B |